Biotech · Private company
Samsung Bioepis Co., Ltd.
Track this companyFree. Adds Samsung Bioepis Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Eylea (Aflibercept)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Lucentis (ranibizumab)Phase 3 · Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- SB11 (Proposed ranibizumab biosimilar)Phase 3 · Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- SB15 (Proposed aflibercept biosimilar)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- DenosumabPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- E303Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- SB26Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid TumorsPHASE1 · RECRUITING · started Mar 23, 2026ClinicalTrials.gov NCT07524348 · fetched Nov 12, 2026
- Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male SubjectsPHASE1 · COMPLETED · started Oct 19, 2020ClinicalTrials.gov NCT04621318 · fetched Nov 12, 2026
- A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)PHASE3 · COMPLETED · started Jun 23, 2020ClinicalTrials.gov NCT04450329 · fetched Nov 12, 2026
- A Phase I Study of SB26 in Healthy VolunteersPHASE1 · COMPLETED · started Aug 22, 2018ClinicalTrials.gov NCT03630627 · fetched Nov 12, 2026
- A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)PHASE3 · COMPLETED · started Mar 14, 2018ClinicalTrials.gov NCT03150589 · fetched Nov 12, 2026